The consistency approach for the quality control of vaccines

Biologicals

Volumn 36, Issue 1, 2008, Pages 73-77

  Hendriksen, Coenraad ^a,b   Arciniega, Juan L ^c   Bruckner, Lukas ^d   Chevalier, Michel ^e   Coppens, Emmanuelle ^e   Descamps, Johan ^f   Duchêne, Michel ^f   Dusek, David Michael ^g   Halder, Marlies ^h   Kreeftenberg, Hans ^a   Maes, Alexandrine ⁱ   Redhead, Keith ^j   Ravetkar, Satish D ^k   Spieser, Jean Marc ^l   Swam, Hanny ^m  

^a NETHERLANDS VACCINE INSTITUTE   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^d INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (Switzerland)

^e SANOFI PASTEUR   (France)

^f GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^g UNITED STATES DEPARTMENT OF AGRICULTURE   (United States)

^h JOINT RESEARCH CENTRE   (Italy)

ⁱ SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^j Intervet UK   (United Kingdom)

^k India Ltd   (India)

^l European Network of National Information Centers   (France)

^m INTERVET INTERNATIONAL BV   (Netherlands)

more..

Author keywords

Consistency; In vitro; Quality control; Release testing; Vaccines

Indexed keywords

VACCINE;

ARTICLE; DRUG MANUFACTURE; DRUG QUALITY; HEALTH CARE ORGANIZATION; PRIORITY JOURNAL; QUALITY CONTROL; STANDARDIZATION; WORLD HEALTH ORGANIZATION;

ANIMALS; HUMANS; QUALITY CONTROL; VACCINES;

ANIMALIA;

EID: 38349193094     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2007.05.002     Document Type: Article

References (14)

1. Virus-Serum-Toxin Act. The Act of March 4, 1913. 37 Stat. 832-833
2. Jones C., and Currie F. Control of components of bacterial polysaccharide vaccines by physical methods. Biologicals 19 (1991) 41-47
3. Metz B, Brunel F, Chamberlin C, van der Gun J, Halder M, Jiskoot W, et al. The potential of physicochemical and immunochemical assays to replace animal tests in the quality control of toxoid vaccines. ATLA 35, in press.
4. Hendriksen C.F.M. Towards eliminating the use of animals for regulatory required vaccine quality control. ALTEX 23 (2006) 187-191
5. Metz B., Jiskoot W., Hennink W.E., Crommelin D.J., and Kersten G.F.M. Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines. Vaccine 12 (2003) 156-167
6. Metz B. Structural characterisation of diphtheria toxoid. Thesis. PrintPartners Ipskamp B.V., Enschede, Netherlands; 2005. ISBN: 90-393-3941-4.
7. Dellepiane N., Griffiths E., and Milstien J.B. New challenges in assuring vaccine quality. Bull World Health Organ 78 (2000) 155-162
8. Hendriksen C.F.M., and van der Gun J. Animal models and alternatives in the quality control of vaccines: are in vitro methods or in vivo methods the scientific equivalent of the emperor's clothes. ATLA 23 (1995) 61-73
9. Jerne N.K., and Maaløe O. Standardization of diphtheria toxoid. Some theoretical and practical considerations. Bull World Health Organ 2 (1949) 49-57
10. Council of Europe. Vaccines for human use. European pharmacopoeia. 5th ed. (2006), Council of Europe, Strasbourg, France Suppl. 5.4, 3838-3840
11. Milstien J.B. Regulation of vaccines: strengthening the science base. J Public Health Policy 25 (2004) 173-189
12. Metz B., Hendriksen C.F.M., Jiskoot W., and Kersten G.F.M. Reduction of animal use in human vaccine quality control: opportunities and problems. Vaccine 20 (2002) 2411-2430
13. White J.L., and Helm S.L. Characterization of aluminium-containing adjuvants. Dev Biol 103 (2000) 217-228
14. Wittayanukulluk A., Jiang D., Regnier F.E., and Hem S.L. Effect of microenvironment pH of aluminium hydroxide adjuvant on the chemical stability of adsorbed antigen. Vaccine 22 (2004) 1172-1176